Results 151 to 160 of about 11,219 (248)

A Delphi consensus on integrating novel therapies into the management of generalized myasthenia gravis. [PDF]

Ther Adv Neurol Disord
Vissing J, Zimprich F, Atula S, Chan A, Andersen H, Topakian R, Tannemaat MR, Weber KP, Cetin H, Neuwirth C, Kuusisto H, Loescher WN.   +11 more
europepmc   +1 more source

Minimal Symptom Expression in Generalized Myasthenia Gravis: A Valuable Patient-Centric Treatment Goal. [PDF]

Eur J Neurol
Meisel A, Uzawa A, Qi CZ, Nowacek D, Guptill J, Howard JF.   +5 more
europepmc   +1 more source

Very Late-Onset Generalized Myasthenia Gravis Presenting With Worsening Frailty. [PDF]

Cureus
Saxena P, Bhutani P, Sachidanand S, Choudhary N, Dhar M.   +4 more
europepmc   +1 more source

Cardiopulmonary exercise testing in mild generalized myasthenia gravis: an exploratory pilot feasibility study. [PDF]

Front Physiol
Stascheit F, Lauermann M, Risch L, Mayer F, Hoffmann S, Meisel A, Roecker K, Cassel M.   +7 more
europepmc   +1 more source

A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis. [PDF]

Curr Neuropharmacol
Ma C, Shen J, Zhu Y, Zhu R.
europepmc   +1 more source

Grace Face Sign in Generalized Myasthenia Gravis (MG)

Neurology India, 2023
Reshma S, Shaik, Sandhya, Manorenj
openaire   +3 more sources

Telitacicept for refractory AChR-positive generalized myasthenia gravis: a retrospective real-world study. [PDF]

Front Immunol
Rong X, Sun X, Wang L, Qu M, Jiang L, Liu M.   +5 more
europepmc   +1 more source

Factors Influencing the Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Retrospective Cohort Study. [PDF]

J Ophthalmol
Chuenkongkaew W, Chirapapaisan N, Chatchutimakorn P, Rattanathamsakul N, Joradoln M, Kongthanasomboon P, Eiamsamarng A.   +6 more
europepmc   +1 more source

Nipocalimab in the management of generalized myasthenia gravis: a new targeted therapeutic approach. [PDF]

Ann Med Surg (Lond)
Khalid M, Haider E, Khan A, Haider NU.
europepmc   +1 more source

Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study. [PDF]

J Neurol
Oeztuerk M, Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, Lehnerer S, Stein M, Schubert C, Schneider-Gold C, Pfeuffer S, Krämer HH, Konen FF, Skripuletz T, Pawlitzki M, Rehmann R, Arat E, Menskes CB, Glaubitz S, Zschüntzsch J, Scherwietes V, Totzeck A, Hagenacker T, Meisel A, Meuth SG, Ruck T.   +26 more
europepmc   +1 more source